Frontier Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$21K Sell
10,500
-10,000
-49% -$20K ﹤0.01% 388
2022
Q1
$41K Buy
+20,500
New +$41K ﹤0.01% 395